title: Posterior reversible encephalopathy syndrome (PRES) associated with ovarian cancer and voltage-gated potassium channel antibodies: A case report.
abstract: •We report a case of PRES in conjunction with high grade serous ovarian carcinoma•There is a documented association between chemotherapy agents and PRES•Paraneoplastic panel was positive for voltage-gated potassium channel antibodies•Paraneoplastic workup may be justified in cases with high suspicion of PRES.
authors.affiliation: Department of Obstetrics and Gynecology, Division of Gynecology Oncology, University of Cincinnati, 231 Albert Sabin Way, Academic Health Center, PO Box 670526, Cincinnati, OH, 45267-0526, United States.
authors.forename: Laura K
authors.initials: LK
authors.lastname: Hadad
authors.affiliation: Department of Obstetrics and Gynecology, Division of Gynecology Oncology, University of Cincinnati, 231 Albert Sabin Way, Academic Health Center, PO Box 670526, Cincinnati, OH, 45267-0526, United States.
authors.forename: Caroline C
authors.initials: CC
authors.lastname: Billingsley
keywords: Gemcitabine; Ovarian cancer; Paraneoplastic syndrome; Posterior reversible encephalopathy syndrome (PRES); Voltage-gated potassium channel antibodies